Arterial Ischaemic Stroke, a more user friendly and accessible treatment modality.
Am I the only one who sees this as exciting?
Up till now the market opportunities are narrow.
This is another move to force open the rusty door leading to a massively big room.
Not yet locked in. Not yet guaranteed.
But I AM excited.
Ann: PRENUMBRA formulation completed for clinical trial use, page-2
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.53 |
Change
0.290(1.90%) |
Mkt cap ! $777.7M | |||
| Open | High | Low | Value | Volume |
| $15.35 | $15.55 | $15.03 | $861.9K | 56.02K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 164 | $15.38 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.53 | 512 | 1 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| CUV (ASX) Chart |